Skip to main content

Table 1 Radiopharmaceuticals and source regions

From: Joint EURADOS-EANM initiative for an advanced computational framework for the assessment of external dose rates from nuclear medicine patients

Radiopharmaceutical

Source regions

99mTc-HDP/MDP

Urinary bladder content, kidneys, bone and the remainder

18FDG

Urinary bladder content, kidneys, liver, blood, brain, hearth, lungs, pancreas, spleen and the remainder

Na131I

Urinary bladder content, kidneys, liver, blood, salivary glands, stomach wall, thyroid, small intestine content, right, left and recto-sigmoid colon content and the remainder